FDA Brief

Company record

Estaderma

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Estaderma.

Warning letters

  1. Estaderma

    FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.

    High risk